SXTC
China SXT Pharmaceuticals, Inc.
$2.46
+0.07 (+2.93%)
At close · Jul 7
Market Cap
$79.26M
Shares
32,218,077
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-06 | — | |
| 20-F | 2026-07-01 | 2026-03-31 | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-04 | — | |
| 6-K | 2026-04-09 | — | |
| 6-K | 2026-01-13 | — | |
| 6-K | 2025-12-31 | 2025-09-30 | |
| 20-F | 2025-07-31 | 2025-03-31 | |
| 6-K | 2025-07-29 | — | |
| 6-K | 2025-07-15 | — | |
| 6-K | 2025-06-16 | — | |
| 6-K | 2025-05-13 | — | |
| 6-K | 2025-03-28 | 2024-09-30 | |
| 6-K | 2025-03-19 | — | |
| 6-K | 2025-01-27 | — | |
| 6-K | 2025-01-23 | — | |
| 6-K | 2024-10-15 | — | |
| 20-F | 2024-08-13 | 2024-03-31 | |
| 6-K | 2024-05-14 | — | |
| 6-K | 2024-04-05 | 2023-09-30 | |
| 20-F | 2023-07-31 | 2023-03-31 | |
| 6-K | 2023-03-23 | — | |
| 6-K | 2023-02-28 | — | |
| 6-K | 2023-02-24 | 2022-09-30 | |
| 6-K | 2022-12-23 | 2022-12-22 | |
| 6-K | 2022-10-12 | — | |
| 6-K | 2022-09-27 | — | |
| 20-F | 2022-07-18 | 2022-03-31 | |
| 6-K | 2022-05-13 | — | |
| 6-K | 2022-05-11 | — | |
| 6-K | 2022-03-24 | — | |
| 6-K | 2022-03-16 | — | |
| 6-K | 2022-02-09 | 2022-02-08 | |
| 6-K | 2022-01-31 | — | |
| 6-K | 2022-01-21 | 2022-01-20 | |
| 6-K | 2022-01-14 | 2021-09-30 | |
| 20-F | 2021-08-13 | 2021-03-31 | |
| 6-K | 2021-05-26 | — | |
| 6-K | 2021-05-17 | — | |
| 6-K | 2021-04-08 | 2020-04-08 | |
| 6-K | 2021-03-03 | 2021-03-02 | |
| 6-K | 2021-02-16 | — | |
| 6-K | 2021-02-03 | — | |
| 6-K | 2021-01-28 | 2020-09-30 | |
| 6-K | 2020-12-03 | 2020-12-01 | |
| 20-F | 2020-07-31 | 2020-03-31 | |
| 6-K | 2020-07-10 | — | |
| 6-K | 2020-04-22 | 2019-09-30 | |
| 6-K | 2020-03-31 | — | |
| 6-K | 2020-03-10 | — |
Showing 1–50 of 52 filings
Key facts
CIK
1723980
CUSIP
G2161P165